-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 R23hSEbebbBhGZgrRT0vftk8wx1NJBlUfZ1nUkN89tdiN8osgldEtyVhzXZVp0IJ
 ofsO4Xl+Svp0AXTA/E5mcQ==

<SEC-DOCUMENT>9999999997-05-005368.txt : 20050215
<SEC-HEADER>9999999997-05-005368.hdr.sgml : 20050215
<ACCEPTANCE-DATETIME>20050215101617
<PAPER>
ACCESSION NUMBER:		9999999997-05-005368
CONFORMED SUBMISSION TYPE:	REGDEX
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		
FILED AS OF DATE:		20050118
DATE AS OF CHANGE:		20050215
EFFECTIVENESS DATE:		20050118

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RA Capital Biotech Fund LP
		CENTRAL INDEX KEY:			0001315082

	FILING VALUES:
		FORM TYPE:		REGDEX
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	021-74043
		FILM NUMBER:		05003126

	BUSINESS ADDRESS:	
		STREET 1:		111 HUNTINGTON AVE
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02199

	MAIL ADDRESS:	
		STREET 1:		111 HUNTINGTON AVE
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02199
</SEC-HEADER>
<DOCUMENT>
<TYPE>REGDEX
<SEQUENCE>1
<FILENAME>9999999997-05-005368.paper
<DESCRIPTION>AUTO-GENERATED PAPER DOCUMENT
<TEXT>
This document was generated as part of a paper submission.
Please reference the Document Control Number 05003126 for access to the original document.
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----